Phase I dose escalation study of SR271425 administered as 24-hour intravenous continuous infusion in patients with refractory solid tumors / F. De Braud, C.S.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 1527-7755. - 23:16 suppl.(2005 Jun), pp. S220-S220. (41. Annual Meeting of the American Society of Clinical Oncology : 13-17 May Orlando (Florida) 2005).
Phase I dose escalation study of SR271425 administered as 24-hour intravenous continuous infusion in patients with refractory solid tumors
F. De BraudPrimo
;G. Curigliano;
2005
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
